Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 416

1.

Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.

Rades D, Motisi L, Veninga T, Conde-Moreno A, Cacicedo J, Schild SE.

Clin Lung Cancer. 2019 Jul;20(4):322-329. doi: 10.1016/j.cllc.2019.04.005. Epub 2019 Apr 26.

PMID:
31155476
2.

Radiotherapy for prostate cancer: DISCERN quality assessment of patient-oriented websites in 2018.

Janssen S, Fahlbusch FB, Käsmann L, Rades D, Vordermark D.

BMC Urol. 2019 May 28;19(1):42. doi: 10.1186/s12894-019-0474-4.

3.

A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.

Janssen S, Hansen HC, Dziggel L, Schild SE, Rades D.

Radiol Oncol. 2019 May 8;53(2):219-224. doi: 10.2478/raon-2019-0020.

4.

Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.

Rades D, Hansen HC, Janssen S, Schild SE.

Anticancer Res. 2019 May;39(5):2569-2574. doi: 10.21873/anticanres.13379.

PMID:
31092454
5.

In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations.

Boda-Heggemann J, Jahnke A, Chan MKH, Ernst F, Ghaderi AL, Attenberger U, Hunold P, Schäfer JP, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O.

Radiother Oncol. 2019 May;134:158-165. doi: 10.1016/j.radonc.2019.01.023. Epub 2019 Feb 15.

PMID:
31005210
6.

Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool.

Hansen HC, Janssen S, Schild SE, Rades D.

Anticancer Res. 2019 Apr;39(4):2091-2095. doi: 10.21873/anticanres.13321.

PMID:
30952754
7.

A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.

Rades D, Hansen HC, Schild SE, Janssen S.

Lung. 2019 Jun;197(3):321-326. doi: 10.1007/s00408-019-00223-6. Epub 2019 Mar 29.

PMID:
30927058
8.

Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients.

Ranjbar M, Prasuhn M, Kurz M, Holzhey A, Rommel F, Brinkmann MP, Rades D, Grisanti S.

J Curr Ophthalmol. 2019 Jan 2;31(1):92-94. doi: 10.1016/j.joco.2018.12.004. eCollection 2019 Mar.

9.

Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.

Rades D, Sehmisch L, Hansen HC, Dziggel L, Janssen S, Schild SE.

Anticancer Res. 2019 Mar;39(3):1501-1505. doi: 10.21873/anticanres.13268.

PMID:
30842188
10.

Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.

Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D.

Anticancer Res. 2019 Mar;39(3):1343-1346. doi: 10.21873/anticanres.13247.

PMID:
30842167
11.

Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.

Stera S, Balermpas P, Blanck O, Wolff R, Wurster S, Baumann R, Szücs M, Loutfi-Krauss B, Wilhelm ML, Seifert V, Rades D, Rödel C, Dunst J, Hildebrandt G, Arnold A, Meissner M, Kähler KC.

Melanoma Res. 2019 Apr;29(2):187-195. doi: 10.1097/CMR.0000000000000542.

PMID:
30802230
12.

Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.

Rades D, Hansen HC, Janssen S, Schild SE.

Cancers (Basel). 2019 Feb 16;11(2). pii: E233. doi: 10.3390/cancers11020233.

13.

Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO).

Carl J, Rades D, Doemer C, Setter C, Dunst J, Holländer NH.

Radiat Oncol. 2019 Jan 10;14(1):3. doi: 10.1186/s13014-019-1209-0.

14.

A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Schild SE.

Radiat Oncol. 2018 Dec 29;13(1):257. doi: 10.1186/s13014-018-1203-y.

15.

Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer.

Rades D, Panzner A, Janssen S, Dunst J, Veninga T, Holländer NH, Schild SE.

Anticancer Res. 2018 Dec;38(12):6897-6903. doi: 10.21873/anticanres.13066.

PMID:
30504407
16.

A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.

Rades D, Vogelsang RP, Treder M, Janssen S, Schild SE, Holländer NH, Gögenur I.

Anticancer Res. 2018 Dec;38(12):6877-6880. doi: 10.21873/anticanres.13063.

PMID:
30504404
17.

Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.

Rades D, Sondermann L, Motisi L, Janssen S, Cacicedo J, Schild SE.

Anticancer Res. 2018 Dec;38(12):6841-6846. doi: 10.21873/anticanres.13058.

PMID:
30504399
18.

Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?

Hansen HC, Janssen S, Thieme C, Perlov A, Schild SE, Rades D.

Anticancer Res. 2018 Dec;38(12):6835-6840. doi: 10.21873/anticanres.13057.

PMID:
30504398
19.

Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review.

Lawton AJ, Lee KA, Cheville AL, Ferrone ML, Rades D, Balboni TA, Abrahm JL.

J Clin Oncol. 2019 Jan 1;37(1):61-71. doi: 10.1200/JCO.2018.78.1211. Epub 2018 Nov 5.

PMID:
30395488
20.

Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer.

Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D.

In Vivo. 2018 Nov-Dec;32(6):1481-1484. doi: 10.21873/invivo.11403.

21.

Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis.

Bezdek S, Leng L, Busch H, Mousavi S, Rades D, Dahlke M, Zillikens D, Bucala R, Sadik CD.

Front Immunol. 2018 Oct 2;9:2262. doi: 10.3389/fimmu.2018.02262. eCollection 2018.

22.

Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.

Witte HM, Riecke A, Mayer T, Bartscht T, Rades D, Lehnert H, Merz H, Fetscher S, Biersack H, Gebauer N.

J Cancer Res Clin Oncol. 2019 Jan;145(1):129-136. doi: 10.1007/s00432-018-2772-8. Epub 2018 Oct 16.

PMID:
30327940
23.

Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.

Treder M, Janssen S, Holländer NH, Schild SE, Rades D.

Anticancer Res. 2018 Sep;38(9):5371-5377. doi: 10.21873/anticanres.12866.

PMID:
30194191
24.

Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.

Oria VO, Bronsert P, Thomsen AR, Föll MC, Zamboglou C, Hannibal L, Behringer S, Biniossek ML, Schreiber C, Grosu AL, Bolm L, Rades D, Keck T, Werner M, Wellner UF, Schilling O.

Transl Oncol. 2018 Dec;11(6):1307-1322. doi: 10.1016/j.tranon.2018.08.001. Epub 2018 Aug 30.

25.

Preliminary Results from a Prospective Study Comparing White Blood Cell and Neutrophil Counts from a Laboratory to Those Measured with a New Device in Patients with Breast Cancer.

Lohman AC, VAN Rijn I, Lindhardt CL, Vonthein R, Rades D, Holländer NH.

In Vivo. 2018 Sep-Oct;32(5):1283-1288. doi: 10.21873/invivo.11378.

26.

Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer.

Rades D, Staackmann C, Janssen S.

Anticancer Res. 2018 Aug;38(8):4833-4837. doi: 10.21873/anticanres.12794.

PMID:
30061256
27.

A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.

Staackmann C, Janssen S, Schild SE, Rades D.

Anticancer Res. 2018 Jul;38(7):4199-4202. doi: 10.21873/anticanres.12714.

PMID:
29970550
28.

Inhibition of GSK3α/β impairs the progression of HNSCC.

Schulz L, Pries R, Lanka AS, Drenckhan M, Rades D, Wollenberg B.

Oncotarget. 2018 Jun 12;9(45):27630-27644. doi: 10.18632/oncotarget.25250. eCollection 2018 Jun 12.

29.

A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy.

Rades D, Dziggel L, Schild SE.

In Vivo. 2018 Jul-Aug;32(4):825-828. doi: 10.21873/invivo.11314.

30.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

31.

An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.

Janssen S, Hansen HC, Schild SE, Rades D.

Anticancer Res. 2018 Jun;38(6):3753-3756. doi: 10.21873/anticanres.12656.

PMID:
29848738
32.

Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.

Rades D, Bartscht T, Idel C, Schild SE, Hakim SG.

Anticancer Res. 2018 Jun;38(6):3653-3656. doi: 10.21873/anticanres.12641.

PMID:
29848723
33.

Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.

Bolm L, Käsmann L, Paysen A, Karapetis C, Rades D, Wellner UF, Keck T, Watson DI, Hummel R, Hussey DJ.

Anticancer Res. 2018 Jun;38(6):3231-3242. doi: 10.21873/anticanres.12588. Review.

PMID:
29848670
34.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
35.

Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

Cacicedo J, Gómez-Iturriaga A, Navarro A, Morillo V, Willisch P, Lopez-Guerra JL, Illescas A, Casquero F, Del Hoyo O, Ciervide R, Martinez-Indart L, Bilbao P, Rades D.

J Med Imaging Radiat Oncol. 2018 May 23. doi: 10.1111/1754-9485.12749. [Epub ahead of print]

PMID:
29797486
36.

Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention.

Janssen S, Rades D, Meyer A, Fahlbusch FB, Wildfang I, Meier A, Schild S, Christiansen H, Henkenberens C.

Strahlenther Onkol. 2018 Sep;194(9):806-814. doi: 10.1007/s00066-018-1315-1. Epub 2018 May 23.

PMID:
29796694
37.

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma.

Witte H, Biersack H, Kopelke S, Rades D, Merz H, Bernard V, Lehnert H, Fetscher S, Gebauer N.

Br J Haematol. 2019 Mar;184(5):869-873. doi: 10.1111/bjh.15198. Epub 2018 May 22. No abstract available.

PMID:
29785776
38.

Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration.

Ranjbar M, Kurz M, Holzhey A, Rades D, Grisanti S.

Ophthalmic Surg Lasers Imaging Retina. 2018 May 1;49(5):320-328. doi: 10.3928/23258160-20180501-05.

PMID:
29772042
39.

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma.

Witte H, Biersack H, Kopelke S, Rades D, Merz H, Bernard V, Lehnert H, Gebauer N.

Oncotarget. 2018 Apr 13;9(28):19613-19622. doi: 10.18632/oncotarget.24701. eCollection 2018 Apr 13.

40.
41.
42.

Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder.

Rades D, Dziggel L, Manig L, Janssen S, Khoa MT, Duong VN, Khiem VH, Schild SE.

In Vivo. 2018 May-Jun;32(3):633-636.

43.

Improvement of dose calculation in radiation therapy due to metal artifact correction using the augmented likelihood image reconstruction.

Ziemann C, Stille M, Cremers F, Buzug TM, Rades D.

J Appl Clin Med Phys. 2018 May;19(3):227-233. doi: 10.1002/acm2.12325. Epub 2018 Apr 17.

44.

Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.

Rades D, Dziggel L, Janssen S, Khoa MT, Duong VN, Khiem VH, Gebauer N, Bartscht T, Schild SE.

Anticancer Res. 2018 Apr;38(4):2415-2418.

PMID:
29599370
45.

Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.

Dziggel L, Gebauer N, Bartscht T, Schild SE, Rades D.

Anticancer Res. 2018 Apr;38(4):2391-2394.

PMID:
29599366
46.

A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers.

Rades D, Seidl D, Janssen S, Hakim SG, Wollenberg B, Bartscht T, Schild SE.

Anticancer Res. 2018 Mar;38(3):1611-1613.

PMID:
29491092
47.

Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases.

Rades D, Blanck O, Khoa MT, VAN Thai P, Hung NQ, Dziggel L, Schild SE.

In Vivo. 2018 Mar-Apr;32(2):381-384.

48.

Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.

Narvaez C, Doemer C, Idel C, Setter C, Olbrich D, Ujmajuridze Z, Carl JH, Rades D.

BMC Cancer. 2018 Feb 17;18(1):197. doi: 10.1186/s12885-018-4119-x.

49.

1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.

Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, Rudat V, Schild SE.

Radiat Oncol. 2018 Feb 8;13(1):21. doi: 10.1186/s13014-018-0968-3.

50.

Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.

Boda-Heggemann J, Jahnke A, Chan MKH, Ghaderi Ardekani LS, Hunold P, Schäfer JP, Huttenlocher S, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O.

Strahlenther Onkol. 2018 May;194(5):414-424. doi: 10.1007/s00066-018-1271-9. Epub 2018 Feb 5.

PMID:
29404626

Supplemental Content

Support Center